
90779-69-4
- Product Name:Atosiban Acetate
- Molecular Formula:C43H67N12O38S2
- Purity:99%
- Molecular Weight:994.19
Product Details;
CasNo: 90779-69-4
Molecular Formula: C43H67N12O38S2
Appearance: solid
Factory supply Atosiban Acetate 90779-69-4 with sufficient stock and high standard We supply high quality Atosiban (CAS 90779-69-4), in stock, factory directly supply to clients, lower prices, more competitiveness.
What is the Atosiban ?
Atosiban is solid, while it's Molecular Formula is C43H67N12O38S2. Atosiban has been used:as an oxytocin receptor antagonistin the calcium mobilization assay for Z factor determination in uterine myometrium (UT-myo cells) and as a therapeutic agent to inhibit preterm laborto inhibit the activation of oxytocin-receptor-expressing neurons in the parabrachial nucleus of mice (OxtrPBN)
What is the CAS number for Atosiban ?
The CAS number of Atosiban is 90779-69-4.
More information of Atosiban 90779-69-4 are:
Synonyms |
Oxytocin,1-(3-mercaptopropanoicacid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithine-;Antocile;Antocin;Antocin II;CAP 449;CAP 476;CAP 581;F 314;ORF 22164;RW22164;RWJ 22164;Tractocil;Tractocile;Atosiban Acetate; |
CAS Number |
90779-69-4 |
Molecular Formula |
C43H67N12O38S2 |
Molecular Weight |
994.19 |
Density |
1.254 g/cm3 |
Boiling Point |
1469 °C at 760 mmHg |
Flash Point |
842.2 °C |
HS CODE |
2934999090 |
PSA |
416.27000 |
LogP |
1.42000 |
Pka |
12.81±0.70(Predicted) |
What is Atosiban (90779-69-4) used for?
Atosiban was introduced in the UK as an injectable inhibitor of preterm labor, a major cause of infant morbidity and mortality. This peptidic oxytocin analog is an antagonist of the vasopressin V1a receptor and of the oxytocin receptor which is found in dramatically increased concentration in the uterine myometrium of pregnant women near term. It competitively inhibited contractions in the pregnant guinea pig uterus induced by oxytocin and vasopressin. In a multicenter, double-blind, placebo-controlled trial, treatment with atosiban caused pregnancy prolongation for up to 7 days in women with more than 28 weeks of gestation. In a comparative clinical trial, atosiban showed a comparable tocolytic action (uterine relaxant) to ritodrine but the former was significantly better tolerated, especially with regards to maternal cardiovascular side effects. In healthy volunteers, plasma levels of atosiban decreased bi-exponentially with an initial and a terminal half-life of 21 min and 1.7h respectively.
InChI:InChI=1/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36?/m0/s1
Articles related to Atosiban:
How to get the best price on Atosiban?
Hangzhou Shanyi Biotechnology Co., Ltd. is a quality supplier and manufacturer of Atosiban . You can buy high quality, low price Atosiban 90779-69-4 here. Contact us.
Relevant Products
-
Eptifibatide
CAS:188627-80-7
-
2-Amino-5-iodobenzonitrile
CAS:132131-24-9
-
Terlipressin Acetate
CAS:14636-12-5